PC
AGN

PA Capital’s Allergan plc AGN Stock Holding History

PA Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,949
Closed -$1.41M – 210
2020
Q1 		$1.41M Buy
7,949
+4,710
+145% +$887K 1.25% 17
2019
Q4 		$619K Sell
3,239
-349
-10% -$63K 0.55% 73
2019
Q3 		$604K Buy
+3,588
New +$585K 0.59% 67

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

PA Capital's AGN Position: Q2 2020 in Review

PA Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,949 shares — an estimated $1.41M sold.

PA Capital first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $1.41M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • PA Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • PA Capital sold 7,949 Allergan plc shares in Q2 2020, an estimated $1.41M.
  • PA Capital first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • PA Capital's Allergan plc position peaked at $1.41M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on PA Capital's 13F filing for Q2 2020, filed 13 Aug 2020.